Meeting
2023 ASCO Annual Meeting
10-year outcomes of technically unresectable oral cancers with neoadjuvant chemotherapy: Real-world data and implications for clinical practice.
Authors
Aditya Dhanawat
Tata Memorial Centre, Mumbai, India
Aditya Dhanawat , Vijay Maruti Patil , Vanita Noronha , Nandini Sharrel Menon , Ajaykumar Chandrabhan Singh , Pankaj Chaturvedi , Prathamesh S Pai , Devendra A Chaukar , Sarbani Ghosh Laskar , Kumar Prabhash
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6085)
DOI
10.1200/JCO.2023.41.16_suppl.6085
Abstract #
6085
Poster Bd #
77
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Phase 3 randomized study comparing docetaxel-platinum with docetaxel-platinum-5 fluorouracil as neoadjuvant chemotherapy in technically unresectable oral cancer.
First Author: Ajaykumar Singh
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Efficacy of sequential perioperative FOLFIRNOX plus gemcitabine nab-paclitaxel for resected pancreatic and periampullary cancers.
First Author: Putao Cen
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Docetaxel-based triplet neoadjuvant therapy for esophageal adenocarcinoma: A comprehensive analysis of outcomes spanning over a decade.
First Author: James Tankel
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Locally advanced esophageal cancer: Evaluation of prognosis by assessment of the “yp” stage based on the neoadjuvant regimen received.
First Author: Indika Gunadasa